Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Enteropathy-Associated T-Cell Lymphoma × fludarabine phosphate × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 50 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Myelodysplastic Syndromes 37 Leukemia, Lymphocytic, Chronic, B-Cell 27 Lymphoma, Non-Hodgkin 25 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18 Multiple Myeloma 16 Leukemia 16 Hodgkin Disease 16 Lymphoma, Follicular 15 Leukemia, Biphenotypic, Acute 14 Lymphoma, Large B-Cell, Diffuse 13 Leukemia, Myelomonocytic, Chronic 13 Hematologic Neoplasms 13 Myeloproliferative Disorders 12 Melanoma 12 Lymphoma, Mantle-Cell 12 Lymphoma 12 Anemia, Refractory, with Excess of Blasts 12 Lymphoma, B-Cell 11 Burkitt Lymphoma 11 Recurrence 10 Lymphoma, B-Cell, Marginal Zone 9 Primary Myelofibrosis 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms 6 Neuroblastoma 5 Neoplasm, Residual 5 Neoplasm Metastasis 5 Leukemia, Myeloid, Accelerated Phase 5

Interventions

Cyclophosphamide 3 etoposide phosphate 2 Prednisone 2 Etoposide 2 Doxorubicin 2 Brentuximab Vedotin 2 tazemetostat 1 prednylidene 1 pembrolizumab 1 fludarabine 1 deltacortene 1 Vincristine 1 Prednisolone 1 Melphalan 1 Cytarabine 1 Cholecalciferol 1 Carmustine 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡